BENEDETTI, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 6.315
EU - Europa 3.154
AS - Asia 833
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 5
SA - Sud America 4
OC - Oceania 2
Totale 10.321
Nazione #
US - Stati Uniti d'America 6.286
UA - Ucraina 780
SE - Svezia 503
IE - Irlanda 439
IT - Italia 439
DE - Germania 348
DK - Danimarca 281
TR - Turchia 253
CN - Cina 215
SG - Singapore 192
FI - Finlandia 155
KR - Corea 150
GB - Regno Unito 144
CA - Canada 29
BE - Belgio 22
FR - Francia 17
PL - Polonia 16
IN - India 11
EU - Europa 7
RS - Serbia 7
EG - Egitto 4
JP - Giappone 4
IR - Iran 3
EC - Ecuador 2
NL - Olanda 2
TW - Taiwan 2
A1 - Anonimo 1
AM - Armenia 1
AU - Australia 1
BR - Brasile 1
CI - Costa d'Avorio 1
CL - Cile 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
VN - Vietnam 1
Totale 10.321
Città #
Chandler 918
Jacksonville 807
Fairfield 575
Dublin 438
Ashburn 370
Wilmington 290
Des Moines 287
Woodbridge 268
Boardman 252
Houston 232
New York 219
Cambridge 188
Centro 182
Seattle 175
Lawrence 174
Princeton 174
San Mateo 166
Ann Arbor 165
San Diego 75
Beijing 50
Turin 45
London 37
Los Angeles 31
Singapore 29
Washington 29
Ottawa 26
Guangzhou 25
Brussels 22
Marche 18
Wuhan 17
Redmond 16
Norwalk 15
Shanghai 14
Kilburn 13
Kraków 13
Torre Annunziata 12
Pune 11
Milan 10
Ancona 9
Helsinki 9
Izmir 9
Wuxi 9
Civitanova Marche 8
Belgrade 7
Chiswick 7
Jiaxing 7
Falls Church 6
Senigallia 6
Acton 4
Jesi 4
Lunano 4
New Bedfont 4
Porto 4
Redwood City 4
Shaoxing 4
Shenzhen 4
Bari 3
Falerone 3
Hounslow 3
Nanjing 3
Naples 3
Palermo 3
Prescot 3
Rosora 3
Seoul 3
Appignano 2
Auburn Hills 2
Bologna 2
Cairo 2
Casoria 2
Fayetteville 2
Florence 2
Jinan 2
L’Aquila 2
Perugia 2
Southend 2
Taichung 2
Tappahannock 2
Venice 2
Yiwu 2
Abbiategrasso 1
Abidjan 1
Acquaviva Picena 1
Amsterdam 1
Andover 1
Ariccia 1
Ascoli Piceno 1
Auckland 1
Aversa 1
Baricella 1
Bitola 1
Bristol 1
Chicago 1
Cuenca 1
Dallas 1
Denver 1
Falkenstein 1
Fiano 1
Gambettola 1
Genoa 1
Totale 6.574
Nome #
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 121
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 113
Increased local dopamine secretion has growth promoting effects in cholangiocarcinoma. 98
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 97
Hepatitis E in a region of Italy: An emerging autochthonous infection? 96
Descriptive epidemiology of cholangiocarcinoma in Italy. 95
Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals 94
Clinical implications of novel aspects of biliary pathophysiology. 92
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 92
Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. 91
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 90
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 90
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritis. 90
Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiation. 89
Exendin-4 restores ppar-alpha and ppar-gamma activity in nash and reduces insulin resistance, pro-inflammatory mediators and total fatty acid content 88
cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway 85
Plasma membrane order parameter in periportal and perivenular hepatocytes isolated from ethanol-treated rats. 85
Primary biliary cirrhosis: modalities of injury and death in biliary epithelium. 84
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 84
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 84
Ethyl caffeoate: Liquid chromatography–tandem mass spectrometric analysis in Verdicchio wine and effects on hepatic stellate cells and intracellular peroxidation 83
Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells. 82
The Na+/H+ exchanger modulates the fibrogenic effect of oxidative stress in rat hepatic stellate cells. 81
Fibrogenic effect of oxidative stress on rat hepatic stellate cells. 79
Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis 79
Ethyl caffeate from Verdicchio wine: chromatographic purification and in vivo evaluation of its antifibrotic activity. 79
Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology 78
Exendin-4, a Glucagon-Like Peptide 1 receptor agonist, protects cholangiocytes from apoptosis 76
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 76
Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent. 75
Transforming growth factor beta 1 increases the number of apoptotic bodies and decreases intracellular pH in isolated periportal and perivenular rat hepatocytes. 75
Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. 75
Leptin enhances cholangiocarcinoma cell growth. 75
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 75
Current targets for Primary Sclerosing cholangitis 75
Cariporide a selective Na+ /H+ exchange inhibitor, reduces PDGF-induced proliferation and oxidative stress product formation in rat hepatic stellate cells (HSC). 75
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 74
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 73
Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3K-mediated pathway. 73
Biologic Drugs in Crohn's Disease and Ulcerative Colitis: Safety Profile 73
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice 72
Postoperative recurrence of crohn’s disease: Pathophysiology, diagnosis and treatment 72
Observer agreement in endoscopic assessment of ulcerative colitis. 71
Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. 71
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. 71
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 71
Selective Na+/H+ inhibition by cariporide reduces liver fibrosis in the rat 70
Aging and the Biological Response to Liver Injury 70
Glucagon-like peptide-1receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced bya high-fat diet in nonalcoholic steatohepatitis 69
Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct ligated rats 68
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency 68
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. 68
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 68
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 68
Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. 67
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 67
Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies 67
Vitamin E in chronic liver diseases and liver fibrosis. 66
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 66
The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. 65
Mycosis Fungoides-like Eruption and Infliximab 65
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 65
Exendin-4, a glucagon-like protein-1 receptor agonist, reduces proinflammatory conditions, and increases lipid oxidation and insulin sensitivity in hepatocytes from nonalcoholic steatohepatitis rats 64
CAMP STIMULATES THE SECRETORY AND PROLIFERATIVE CAPACITY OF THE RAT BILIARY EPITHELIUM THROUGH CHANGES IN THE PKA/SRC/MEK/ERK1/2 PATHWAY 64
Regulation of intracellular pH in isolated periportal and perivenular rat hepatocytes. 64
Age and sex related changes of plasma membrane fluidity in isolated rat hepatocytes 64
Evidence that plasma membrane fluidity of isolated hepatocytes is modified by exposure to microtubule-depolymerizing drugs 64
Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo. 64
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 64
Endoscopy Units and the Coronavirus Disease 2019 Outbreak: A Multicenter Experience From Italy 64
Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver 63
Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation 63
Aging-Related Molecular Pathways in Chronic Cholestatic Conditions 63
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 63
Inhibition of the NA(+)/H(+) exchanger reduces rat hepatic stellate cell activity and liver fibrosis: an in vitro and in vivo study. 63
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells 62
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. 61
An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. 61
Characterization of ion transport mechanisms regulating intracellular pH in hepatic stellate cells. 61
Carrier-mediated transport of conjugated bile acids across the basolateral membrane of biliary epithelial cells. 61
Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic Acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts 60
[Cholestasis. Recent diagnostic and therapeutic acquisitions]. 60
Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor. 60
Oxidative damage and celiac disease: role of the enzyme paraoxonase associated with high-density lipoprotein (HDL) 60
Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat. 58
Endogenous opioid peptides and chronic liver disease: from bedside to bench. 58
Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt 58
Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease. 58
Morphological features and modulation of the intrahepatic biliary epithelium. 58
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis 58
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls 57
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis. 57
Quantitative study of apoptosis in normal rat gastroduodenal mucosa. 57
Gastrin inhibits cholangiocyte growth in bile duct-ligated rats by interaction with cholecystokinin-B/Gastrin receptors via D-myo-inositol 1,4,5-triphosphate-, Ca(2+)-, and protein kinase C alpha-dependent mechanisms. 56
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 56
Effect of cyanidin 3-O-β-glucopyranoside on hepatic stellate cell proliferation and collagen synthesis induced by oxidative stress 56
Subcellular changes and apoptosis induced by ethanol in rat liver. 55
BILE ACIDS INDUCE HEPATIC STELLATE CELL PROLIFERATION VIA ACTIVATION OF THE EPIDERMAL GROWTH FACTOR 55
The significance of genetics for cholangiocarcinoma development 55
mTOR and STAT3 Pathway Hyper-Activation is Associated with evated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment 55
Totale 7.174
Categoria #
all - tutte 59.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.033


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.006 7 3 161 2 158 5 164 0 173 31 57 245
2020/20212.374 147 256 326 70 255 138 221 157 226 201 226 151
2021/20221.435 82 370 23 55 11 64 86 101 74 155 143 271
2022/20232.702 228 285 187 216 190 521 4 171 660 20 154 66
2023/20241.426 265 45 87 243 231 295 24 29 12 26 14 155
2024/202576 76 0 0 0 0 0 0 0 0 0 0 0
Totale 10.576